Inner Mongolia Sheep Fat Completes Cosmetic Ingredient Filing

On November 11, 2026, sheep fat completed filing as a new cosmetic ingredient under filing number 国妆原备字20260168. The filing was made by the Bayannur Meat Sheep Technology Innovation Center in Inner Mongolia and is the center’s first new cosmetic ingredient filing.

Sheep fat is the second new cosmetic ingredient derived from Inner Mongolia’s distinctive resources to complete filing. It has not entered the safety monitoring period, its technical requirements have not been published, and no INCI name is listed.

What the filing establishes

The filing identifies a new cosmetic ingredient and gives it a specific filing number. For the center, it also marks a first entry in this area. Its place as Inner Mongolia’s second filed ingredient of this kind makes it a development for businesses and researchers following the use of regional resources in cosmetics.

The filing itself is a distinct milestone from the steps that could follow. The information available does not establish when safety monitoring will begin, what the ingredient’s published technical requirements will contain, or whether it will appear in cosmetic products. Those questions matter when assessing its practical significance.

Details for formulators and ingredient buyers to follow

The unpublished technical requirements are relevant to anyone considering how the ingredient might fit into a formulation or supply process. Their eventual content could help prospective users understand the filed material more precisely. Until then, the filing alone does not establish detailed specifications or suitable uses.

The absence of a listed INCI name is also relevant to ingredient identification. An INCI name, if listed later, would be a detail for companies tracking how the material is described in cosmetic ingredient information. The current filing number provides the specific reference for this ingredient in the meantime.

Safety monitoring is a separate point to watch. Because the ingredient has not entered that period, the filing should not be described as completion of safety monitoring. Any assessment of its subsequent regulatory status will depend on later information about that process.

For now, the clearest outcome is the completed filing and its significance as the center’s first. Publication of the technical requirements, any listing of an INCI name, and developments in the ingredient’s safety monitoring status are the most directly relevant details to follow.